NCT00942149View on ClinicalTrials.gov

An Open Label Study to Describe the Pharmacokinetics of Daptomycin in Infants

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Sepsis

Interventions

DRUG

Daptomycin

single dose of 6 mg/kg of daptomycin

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

lead

Duke University

OTHER

NCT00942149 - An Open Label Study to Describe the Pharmacokinetics of Daptomycin in Infants | Biotech Hunter | Biotech Hunter